ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 524,74
0,29%
Dow Jones
38 589,16
0,00%
DAX
18 031,53
0,06%
Brent Oil
82,57
0,54%
Bitcoin
65 786,13
-1,28%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Sorrento Therapeutics Inc (CE) (SRNEQ)

  7. Sorrento Therapeutics Inc (CE) (SRNEQ) Actualités

SRNEQ

Sorrento Therapeutics (CE) (SRNEQ)

Sorrento Therapeutics Inc (CE)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:SRNEQ
DateHeureSourceTitreSymboleSociété
07/11/202322h34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
05/10/202323h22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:SRNEQSorrento Therapeutics Inc (CE)
05/10/202323h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SRNEQSorrento Therapeutics Inc (CE)
26/09/202322h49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:SRNEQSorrento Therapeutics Inc (CE)
18/07/202323h23Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:SRNEQSorrento Therapeutics Inc (CE)
21/06/202323h25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:SRNEQSorrento Therapeutics Inc (CE)
20/06/202323h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
15/05/202321h18Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SRNEQSorrento Therapeutics Inc (CE)
09/05/202312h03Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:SRNEQSorrento Therapeutics Inc (CE)
12/04/202314h51Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)USOTC:SRNEQSorrento Therapeutics Inc (CE)
10/04/202323h23Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:SRNEQSorrento Therapeutics Inc (CE)
21/03/202300h54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SRNEQSorrento Therapeutics Inc (CE)
10/03/202317h22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SRNEQSorrento Therapeutics Inc (CE)
 Showing the most relevant articles for your search:USOTC:SRNEQ

Dernières Valeurs Consultées

COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
EU
CS
Axa
NASDAQ
AMZN
Amazon.com
EU
AI
Air Liquide
EU
RNO
Renault
EU
PX4
SBF 120
NYSE
MCD
McDonalds
EU
BN
Danone
EU
ORA
Orange
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
EU
DG
Vinci
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés